575 related articles for article (PubMed ID: 22236189)
1. Deregulated signaling pathways in glioblastoma multiforme: molecular mechanisms and therapeutic targets.
Mao H; Lebrun DG; Yang J; Zhu VF; Li M
Cancer Invest; 2012 Jan; 30(1):48-56. PubMed ID: 22236189
[TBL] [Abstract][Full Text] [Related]
2. Molecular pathways and potential therapeutic targets in glioblastoma multiforme.
Wardak Z; Choe KS
Expert Rev Anticancer Ther; 2013 Nov; 13(11):1307-18. PubMed ID: 24168050
[TBL] [Abstract][Full Text] [Related]
3. Molecular characterizations of glioblastoma, targeted therapy, and clinical results to date.
Bastien JI; McNeill KA; Fine HA
Cancer; 2015 Feb; 121(4):502-16. PubMed ID: 25250735
[TBL] [Abstract][Full Text] [Related]
4. SnapShot: glioblastoma multiforme.
Kotliarova S; Fine HA
Cancer Cell; 2012 May; 21(5):710-710.e1. PubMed ID: 22624719
[No Abstract] [Full Text] [Related]
5. The role of Myc and let-7a in glioblastoma, glucose metabolism and response to therapy.
Wang G; Wang J; Zhao H; Wang J; Tony To SS
Arch Biochem Biophys; 2015 Aug; 580():84-92. PubMed ID: 26151775
[TBL] [Abstract][Full Text] [Related]
6. Transcription factors in glioblastoma - Molecular pathogenesis and clinical implications.
Papavassiliou KA; Papavassiliou AG
Biochim Biophys Acta Rev Cancer; 2022 Jan; 1877(1):188667. PubMed ID: 34894431
[TBL] [Abstract][Full Text] [Related]
7. Natural products as promising targets in glioblastoma multiforme: a focus on NF-κB signaling pathway.
Soukhtanloo M; Mohtashami E; Maghrouni A; Mollazadeh H; Mousavi SH; Roshan MK; Tabatabaeizadeh SA; Hosseini A; Vahedi MM; Jalili-Nik M; Afshari AR
Pharmacol Rep; 2020 Apr; 72(2):285-295. PubMed ID: 32152926
[TBL] [Abstract][Full Text] [Related]
8. Targeting metabolic remodeling in glioblastoma multiforme.
Wolf A; Agnihotri S; Guha A
Oncotarget; 2010 Nov; 1(7):552-62. PubMed ID: 21317451
[TBL] [Abstract][Full Text] [Related]
9. Combined expressional analysis, bioinformatics and targeted proteomics identify new potential therapeutic targets in glioblastoma stem cells.
Stangeland B; Mughal AA; Grieg Z; Sandberg CJ; Joel M; Nygård S; Meling T; Murrell W; Vik Mo EO; Langmoen IA
Oncotarget; 2015 Sep; 6(28):26192-215. PubMed ID: 26295306
[TBL] [Abstract][Full Text] [Related]
10. Mechanism of Notch Signaling Pathway in Malignant Progression of Glioblastoma and Targeted Therapy.
Wang S; Gu S; Chen J; Yuan Z; Liang P; Cui H
Biomolecules; 2024 Apr; 14(4):. PubMed ID: 38672496
[TBL] [Abstract][Full Text] [Related]
11. Survival signalling and apoptosis resistance in glioblastomas: opportunities for targeted therapeutics.
Krakstad C; Chekenya M
Mol Cancer; 2010 Jun; 9():135. PubMed ID: 20515495
[TBL] [Abstract][Full Text] [Related]
12. Aptamer targeting EGFRvIII mutant hampers its constitutive autophosphorylation and affects migration, invasion and proliferation of glioblastoma cells.
Camorani S; Crescenzi E; Colecchia D; Carpentieri A; Amoresano A; Fedele M; Chiariello M; Cerchia L
Oncotarget; 2015 Nov; 6(35):37570-87. PubMed ID: 26461476
[TBL] [Abstract][Full Text] [Related]
13. Cellular signaling molecules as therapeutic targets in glioblastoma multiforme.
Jagannathan J; Prevedello DM; Dumont AS; Laws ER
Neurosurg Focus; 2006 Apr; 20(4):E8. PubMed ID: 16709039
[TBL] [Abstract][Full Text] [Related]
14. Glioblastoma precision therapy: From the bench to the clinic.
Zhou Y; Wu W; Bi H; Yang D; Zhang C
Cancer Lett; 2020 Apr; 475():79-91. PubMed ID: 32004571
[TBL] [Abstract][Full Text] [Related]
15. The role of STAT3 in glioblastoma progression through dual influences on tumor cells and the immune microenvironment.
Chang N; Ahn SH; Kong DS; Lee HW; Nam DH
Mol Cell Endocrinol; 2017 Aug; 451():53-65. PubMed ID: 28089821
[TBL] [Abstract][Full Text] [Related]
16. Targeting the AKT pathway in glioblastoma.
McDowell KA; Riggins GJ; Gallia GL
Curr Pharm Des; 2011; 17(23):2411-20. PubMed ID: 21827416
[TBL] [Abstract][Full Text] [Related]
17. Foretinib induces G2/M cell cycle arrest, apoptosis, and invasion in human glioblastoma cells through c-MET inhibition.
Gortany NK; Panahi G; Ghafari H; Shekari M; Ghazi-Khansari M
Cancer Chemother Pharmacol; 2021 Jun; 87(6):827-842. PubMed ID: 33688998
[TBL] [Abstract][Full Text] [Related]
18. miR128-1 inhibits the growth of glioblastoma multiforme and glioma stem-like cells via targeting BMI1 and E2F3.
Shan ZN; Tian R; Zhang M; Gui ZH; Wu J; Ding M; Zhou XF; He J
Oncotarget; 2016 Nov; 7(48):78813-78826. PubMed ID: 27705931
[TBL] [Abstract][Full Text] [Related]
19. Autophagic and Apoptotic Pathways as Targets for Chemotherapy in Glioblastoma.
Trejo-Solís C; Serrano-Garcia N; Escamilla-Ramírez Á; Castillo-Rodríguez RA; Jimenez-Farfan D; Palencia G; Calvillo M; Alvarez-Lemus MA; Flores-Nájera A; Cruz-Salgado A; Sotelo J
Int J Mol Sci; 2018 Nov; 19(12):. PubMed ID: 30486451
[TBL] [Abstract][Full Text] [Related]
20. Novel Strategies to Discover Effective Drug Targets in Metabolic and Immune Therapy for Glioblastoma.
Wang G; Fu XL; Wang JJ; Guan R; Tang XJ
Curr Cancer Drug Targets; 2017; 17(1):17-39. PubMed ID: 27562399
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
